HeartSciences shares surge 17.02% premarket as UWE adopts MyoVista for ECG education, bolstering UK commercial prospects.

HeartSciences surged 17.02% in premarket trading following the announcement that the University of the West of England (UWE) adopted its MyoVista Insights platform and MyoVista wavECG device as exclusive technologies to establish a national ECG Education and Technology Reference Center. The partnership, a major academic and strategic win, positions HeartSciences’ AI-driven ECG solutions as a core tool for training NHS-focused cardiac scientists and validates the platform’s clinical and educational value. UWE’s status as a leading UK provider of cardiac science education and its alignment with NHS workforce priorities amplify the deal’s significance, strengthening HeartSciences’ commercial positioning in the UK healthcare ecosystem. The collaboration also provides real-world validation to accelerate future clinical adoption discussions with NHS trusts, directly supporting the company’s long-term growth strategy in the AI-ECG market.